KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Shares Issued (2016 - 2025)

Astrana Health's Shares Issued history spans 11 years, with the latest figure at $301000.0 for Q1 2025.

  • For Q1 2025, Shares Issued changed N/A year-over-year to $301000.0; the TTM value through Mar 2025 reached $572000.0, up 110.29%, while the annual FY2024 figure was $271000.0, 82.19% down from the prior year.
  • Shares Issued for Q1 2025 was $301000.0 at Astrana Health, up from $271000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $33.5 million in Q4 2021 and bottomed at -$2.8 million in Q4 2022.
  • The 5-year median for Shares Issued is $1.0 million (2022), against an average of $3.2 million.
  • The largest annual shift saw Shares Issued skyrocketed 508.0% in 2021 before it plummeted 219.5% in 2023.
  • A 5-year view of Shares Issued shows it stood at $33.5 million in 2021, then crashed by 108.3% to -$2.8 million in 2022, then surged by 154.67% to $1.5 million in 2023, then crashed by 82.19% to $271000.0 in 2024, then rose by 11.07% to $301000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Shares Issued are $301000.0 (Q1 2025), $271000.0 (Q3 2024), and $1.5 million (Q4 2023).